ACOR
Acorda Therapeutics, Inc.
ACOR
ACOR
Delisted
ACOR was delisted on the 11th of April, 2024.
163 hedge funds and large institutions have $1.47B invested in Acorda Therapeutics, Inc. in 2014 Q2 according to their latest regulatory filings, with 26 funds opening new positions, 66 increasing their positions, 45 reducing their positions, and 16 closing their positions.
Holders
163
Holders Change
+9
Holders Change %
+5.84%
% of All Funds
4.69%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
26
Increased
66
Reduced
45
Closed
16
Calls
$2.85M
Puts
$4.62M
Net Calls
-$1.77M
Net Calls Change
-$2.7M
Top Buyers
| 1 |
BM
1
Bridger Management
New York
|
$37.8M |
| 2 |
2
Millennium Management
New York
|
$23.8M |
| 3 |
3
Point72 Asset Management
Stamford,
Connecticut
|
$20.8M |
| 4 |
4
Citadel Advisors
Miami,
Florida
|
$26.2M |
| 5 |
5
Fidelity Investments
Boston,
Massachusetts
|
$160M |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
176
Schroder Investment Management Group
London,
United Kingdom
| – | – | -2,302 | Closed |
|
|
DVM
177
Dreman Value Management
West Palm Beach,
Florida
| – | – | -1,526 | Closed |
|
|
TDC
178
Thompson Davis & Co
Richmond,
Virginia
| – | – | -250 | Closed |
|
|
TRCT
179
Tower Research Capital (TRC)
New York
| – | – | -1 | Closed |
|